Sunday 1 October 2023

Week 425 Review - A flat week but Optibiotix sneaks up a little

A generally flat week with a lot of slightly falling shares, but a 1.5p increase in OPTI:Optibiotix reduced the deficit between cost and value by £3,138 to £85,043 and increased total value to £107,608.

Worst performer was CAML:Central Asia Metals which dropped 7%, but that was mainly due to dividend ex-date. However it did send my profitable holding into the red.

Nothing else rose more than 5%, so OPTI:Optibiotix gets Share of the Week after climbing 16% in my cheapest holding to go 184% up, but in my most expensive holding it went up just 1% and is still 70% down.

Here's the ISA and shares portfolio after week 9 of year 9.

Weekly Change
Cash£165.89+£0
Portfolio cost£93,364.33+£0
Portfolio sell value
(bid price-commission)
£50,216.14(-46.2%)+£1,487.10
Potential profits£2,530.20+£282.99
Yr 9 Dividends£15.95+£0
Yr 9 Interest£1.25+£0
Yr 9 Profit from sales£0+£0
Yr 9 proj avg monthly profit£2.17(0.0%)-£0.27
Total Dividends£11,927.38+£0
Total Interest£3.18+£0
Total Profit from sales£17,298.53+£0
Average monthly cash profit£294.04(5.4%)-£0.69
(Sold stocks profit + Dividends
- Fees / Months)
Compound performance44%+0%

Very little happened apart from the OPTI:Optibiotix boost.


Still quite a long way from the high reached a few months ago, and that's with an extra £5k injected.


Happy to be above the trend line which is pointing upwards

The SIPP looks like this after week 409 overall and week 45 of year 8.




Weekly Change
Cash£257.37
+£98.90
Portfolio cost£96,787.56
+£0
Portfolio sell value
(bid price - commission)
£55,507.89(-42.6%)+£1,647.47
Potential profits£3,966.37
+£229.36
Yr 8 Dividends£313.16
+£36.40
Yr 8 Interest£4.26
+£0
Yr 8 Profit from sales-£9,597.85
+£0
Yr 8 proj avg monthly profit-£905.68(-16.6%)+£24.17
Total Dividends£14,455.94
+£36.40
Total Interest£4.51
+£0
Total Profit from sales£10,835.90
+£0
Average monthly cash profit£256.14(4.7%)-£0.24
(Sold stocks profit + Dividends
- Fees / Months)
Compound performance37%+0%

I got a £62 tax rebate and £36 dividends which was made up of £13 from CEY:Centamin, £16 from EDV:Endeavour Mining and £5 from ANTO:Antofagasta. Similar rises in value and potential profits to the ISA thanks to OPTI:Optibiotix.

Still pretty awful


As with the ISA, comfortably above the trend line and dragging it steeper upwards.

The trading account looks like this after week 375 overall and week 11 of year 8.




Weekly Change
Cash£281.80
+£0
Portfolio cost£1,794.51
+£0
Portfolio sell value
(bid price - commission)
£1,179.00(-34.3%)+£4.12
Potential profits£0
+£0
Year 8 Dividends£8.56
+£0
Year 8 Interest£0
+£0
Year 8 Profit£283.99
+£0
Yr 8 proj avg monthly profit£115.25(+77.1%)-£11.52
Dividends£68.66
+£0
Interest£0.03
+£0
Profit from sales-£646.70
+£0
Average monthly cash profit-£6.68(-4.5%)+£0.02
(Sold stocks profit + Dividends
- Fees / Months)

JLP:Jubilee Metals dropped this week, but BARC:Barclays had a great week and is almost in profit, so there was a small £4 rise in value. Will I get to sell BARC soon?


I do believe we're sneaking upwards. It will take a long time to recover from DDDD:4D Pharma going bust though.


Not going up as fast as the trend line so really need a boost.

There was meant to be new coming from OPTI:Optibiotix weeks ago on microbiome modulators and Sweetbiotix, but absolutely zilch. There have been some good murmurings with various pundits though, so hopefully a tickle of interest will at least stop us sliding any lower. Ideally we need to get back to the 40p zone we his a few months ago and hang around there for a bit.

I hoped to get £2k transferred from my pension, but the bond prices seems to have dropped and I don't quite have the minimum amount to allow the transfer, as I have to keep £200 in the account. I'll keep watching in case it creeps past the minimum amount, else I'll have to wait another month. Shame, as I was intending to splash out on more JLP:Jubilee Metals shares, as the current price is crazy. It should be at least double considering the amount of cash being generated, and institutional investors have been increasing their holding.

No comments:

Post a Comment